171 related articles for article (PubMed ID: 20137940)
1. 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
Bursavich MG; Parker DP; Willardsen JA; Gao ZH; Davis T; Ostanin K; Robinson R; Peterson A; Cimbora DM; Zhu JF; Richards B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1677-9. PubMed ID: 20137940
[TBL] [Abstract][Full Text] [Related]
2. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis.
Wójcik C; Yano M; DeMartino GN
J Cell Sci; 2004 Jan; 117(Pt 2):281-92. PubMed ID: 14657277
[TBL] [Abstract][Full Text] [Related]
3. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting valosin-containing protein suppresses osteosarcoma cell metastasis via AKT/nuclear factor of kappa B signaling pathway in vitro.
Long XH; Zhang ZH; Liu ZL; Huang SH; Luo QF
Indian J Pathol Microbiol; 2013; 56(3):190-5. PubMed ID: 24152492
[TBL] [Abstract][Full Text] [Related]
5. Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships.
Polucci P; Magnaghi P; Angiolini M; Asa D; Avanzi N; Badari A; Bertrand J; Casale E; Cauteruccio S; Cirla A; Cozzi L; Galvani A; Jackson PK; Liu Y; Magnuson S; Malgesini B; Nuvoloni S; Orrenius C; Sirtori FR; Riceputi L; Rizzi S; Trucchi B; O'Brien T; Isacchi A; Donati D; D'Alessio R
J Med Chem; 2013 Jan; 56(2):437-50. PubMed ID: 23245311
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the aggregation-prevention activity of p97/valosin-containing protein.
Song C; Wang Q; Li CC
Biochemistry; 2007 Dec; 46(51):14889-98. PubMed ID: 18044963
[TBL] [Abstract][Full Text] [Related]
7. p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation.
Mori-Konya C; Kato N; Maeda R; Yasuda K; Higashimae N; Noguchi M; Koike M; Kimura Y; Ohizumi H; Hori S; Kakizuka A
Genes Cells; 2009 Apr; 14(4):483-97. PubMed ID: 19335618
[TBL] [Abstract][Full Text] [Related]
8. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation.
Dai RM; Li CC
Nat Cell Biol; 2001 Aug; 3(8):740-4. PubMed ID: 11483959
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97.
Ewens CA; Kloppsteck P; Förster A; Zhang X; Freemont PS
Biochem Cell Biol; 2010 Feb; 88(1):41-8. PubMed ID: 20130678
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.
Cervi G; Magnaghi P; Asa D; Avanzi N; Badari A; Borghi D; Caruso M; Cirla A; Cozzi L; Felder E; Galvani A; Gasparri F; Lomolino A; Magnuson S; Malgesini B; Motto I; Pasi M; Rizzi S; Salom B; Sorrentino G; Troiani S; Valsasina B; O'Brien T; Isacchi A; Donati D; D'Alessio R
J Med Chem; 2014 Dec; 57(24):10443-54. PubMed ID: 25474526
[TBL] [Abstract][Full Text] [Related]
11. Xanthohumol impairs autophagosome maturation through direct inhibition of valosin-containing protein.
Sasazawa Y; Kanagaki S; Tashiro E; Nogawa T; Muroi M; Kondoh Y; Osada H; Imoto M
ACS Chem Biol; 2012 May; 7(5):892-900. PubMed ID: 22360440
[TBL] [Abstract][Full Text] [Related]
12. VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal.
Bastola P; Neums L; Schoenen FJ; Chien J
Mol Oncol; 2016 Dec; 10(10):1559-1574. PubMed ID: 27729194
[TBL] [Abstract][Full Text] [Related]
13. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions.
Wang Q; Song C; Li CC
J Struct Biol; 2004; 146(1-2):44-57. PubMed ID: 15037236
[TBL] [Abstract][Full Text] [Related]
14. 2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activity.
Wang S; Meades C; Wood G; Osnowski A; Anderson S; Yuill R; Thomas M; Mezna M; Jackson W; Midgley C; Griffiths G; Fleming I; Green S; McNae I; Wu SY; McInnes C; Zheleva D; Walkinshaw MD; Fischer PM
J Med Chem; 2004 Mar; 47(7):1662-75. PubMed ID: 15027857
[TBL] [Abstract][Full Text] [Related]
15. Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains.
DeLaBarre B; Brunger AT
Nat Struct Biol; 2003 Oct; 10(10):856-63. PubMed ID: 12949490
[TBL] [Abstract][Full Text] [Related]
16. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
Wang Y; Wan B; Zhou J; Li R; Yu L
Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
[TBL] [Abstract][Full Text] [Related]
17. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death.
Magnaghi P; D'Alessio R; Valsasina B; Avanzi N; Rizzi S; Asa D; Gasparri F; Cozzi L; Cucchi U; Orrenius C; Polucci P; Ballinari D; Perrera C; Leone A; Cervi G; Casale E; Xiao Y; Wong C; Anderson DJ; Galvani A; Donati D; O'Brien T; Jackson PK; Isacchi A
Nat Chem Biol; 2013 Sep; 9(9):548-56. PubMed ID: 23892893
[TBL] [Abstract][Full Text] [Related]
18. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
J Clin Oncol; 2003 Jul; 21(13):2537-44. PubMed ID: 12829673
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.
Nadeau MÈ; Rico C; Tsoi M; Vivancos M; Filimon S; Paquet M; Boerboom D
BMC Cancer; 2015 Jun; 15():479. PubMed ID: 26104798
[TBL] [Abstract][Full Text] [Related]
20. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
